Colin MD Broom's Net Worth

$14.1 Million

Estimate Recalculated Sep 9, 2024 12:18AM EST

Who is Colin MD Broom

Colin MD Broom has an estimated net worth of $14.1 Million. This is based on reported shares across multiple companies, which include Nabriva Therapeutics Plc, Nabriva Therapeutics AG, VIROPHARMA INC, and NPS PHARMACEUTICALS INC.

SEC CIK

Colin MD Broom's CIK is 0001289946

Past Insider Trading and Trends

2011 was Colin MD Broom's most active year for acquiring shares with 15 total transactions. Colin MD Broom's most active month to acquire stocks was the month of December. 2014 was Colin MD Broom's most active year for disposing of shares, totalling 32 transactions. Colin MD Broom's most active month to dispose stocks was the month of December. 2012 saw Colin MD Broom paying a total of $702,090.04 for 183,393 shares, this is the most they've acquired in one year. In 2014 Colin MD Broom cashed out on 888,861 shares for a total of $8,705,872.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nabriva Therapeutics Plc

Chief Executive Officer
Updated Jun 27, 2017
Form 4
924.58K
Jun 27, 2017
924.58K
Acq/Dis
Jun 23
Showing 1 results

Nabriva Therapeutics AG

CEO & Director
Updated Aug 04, 2022
Form 4
-12.75%
-5.34K
$0.19
-$1.02K
Aug 04, 2022
36.52K
Sale
Aug 02
Form 4
-1.25%
-531.00
$1.20
-$637.20
Aug 04, 2021
41.86K
Sale
Aug 02
Form 4
210.90%
52.50K
Jul 30, 2021
77.39K
Grant
Jul 28
Form 4
-4.26%
-11.06K
$0.65
-$7.17K
Aug 21, 2020
248.94K
Sale
Aug 19 - Aug 20
Form 4
25.15%
52.50K
Jul 31, 2020
261.25K
Grant
Jul 29
Form 4
5.13%
10.18K
$2.03
$20.67K
Sep 03, 2019
208.75K
Purchase
Aug 30
Form 4/A
-7.49%
-10.18K
$2.07
-$21.07K
Aug 26, 2019
125.72K
Sale
Aug 21
Form 4
-6.00%
-10.18K
$2.07
-$21.07K
Aug 21, 2019
159.47K
Options
Aug 19 - Aug 21
Form 4
35.00K
Aug 01, 2019
35.00K
Grant
Jul 31
Form 4
5.15%
5.00K
$3.72
$18.60K
Jun 25, 2018
175.00K
Purchase
Jun 22
Form 4
11.47%
10.00K
$4.60
$46.00K
May 23, 2018
170.00K
Purchase
May 23
Form 4
267.50K
Feb 02, 2018
267.50K
Grant
Jan 31
Form 4
3.06%
2.59K
$8.35
$21.61K
Sep 26, 2017
160.00K
Purchase
Sep 22
Form 4
26.10K
Feb 09, 2017
26.10K
Grant
Feb 07
Form 3
Dec 30, 2016
15.74K
Showing 15 results

VIROPHARMA INC

VP & Chief Scientific Officer
Updated Jan 28, 2014
Form 4
-100.00%
-662.51K
$50.00
Jan 28, 2014
Disposition
Jan 24
Form 4
-4.89%
-20.14K
$27.51
-$262.40K
Jan 10, 2014
391.92K
Options
Jan 08
Form 4
32.52K
Jun 12, 2013
32.52K
Grant
Jun 10
Form 4
34.57K
Jan 07, 2013
34.57K
Grant
Jan 03
Form 4/A
-46.46%
-17.50K
$22.53
-$394.30K
Dec 28, 2012
20.17K
Sale
ScheduledDec 24
Form 4
$1.84
$18.40K
Dec 28, 2012
150.17K
Options
ScheduledDec 27
Form 4
-10.44%
-17.50K
$12.19
-$362.10K
Dec 27, 2012
150.17K
Sale
ScheduledDec 24
Form 4
-42.21%
-75.00K
$16.38
-$1.15M
Dec 12, 2012
102.67K
Sale
Dec 10
Form 4
35.72K
Jun 06, 2012
35.72K
Grant
Jun 04
Form 4
27.27K
Jan 06, 2012
27.27K
Grant
Jan 05
Form 4
$1.84
$32.20K
Dec 27, 2011
166.94K
Options
Dec 23
Form 4
-72.01%
-50.00K
$17.02
-$831.25K
Dec 15, 2011
19.44K
Sale
ScheduledDec 14
Form 4
-67.30%
-40.00K
$15.28
-$658.07K
Dec 14, 2011
19.44K
Sale
ScheduledDec 12 - Dec 13
Form 4
-33.65%
-20.00K
$13.46
-$301.80K
Nov 08, 2011
39.44K
Sale
Nov 07
Form 4
-69.65%
-44.62K
$11.68
-$762.10K
Nov 02, 2011
19.44K
Sale
Oct 31 - Nov 01
Form 4
40.26K
Jun 07, 2011
40.26K
Grant
Jun 06
Form 4
40.26K
Jan 07, 2011
40.26K
Grant
Jan 05
Form 4
$1.84
$4.60K
Jan 04, 2011
134.94K
Options
Dec 31
Form 4
-18.17%
-30.00K
$7.55
-$342.57K
Sep 13, 2010
135.11K
Sale
Sep 09 - Sep 13
Form 4
50.00K
Jun 09, 2010
50.00K
Grant
Jun 07
Form 4
100.00K
Jan 08, 2010
100.00K
Grant
Jan 07
Form 4
40.00K
Jun 15, 2009
40.00K
Grant
Jun 11
Form 4
60.00K
Jan 12, 2009
60.00K
Grant
Jan 08
Form 4
-67.69%
-25.35K
$8.70
-$312.96K
Sep 16, 2008
12.10K
Sale
Sep 12
Form 4
55.00K
Jun 17, 2008
55.00K
Grant
Jun 13
Form 4
20.00K
Jan 15, 2008
20.00K
Grant
Jan 11
Form 4
40.00K
Jun 19, 2007
40.00K
Grant
Jun 15
Form 4
40.00K
Jan 16, 2007
40.00K
Grant
Jan 12
Form 4
50.00K
Aug 07, 2006
50.00K
Grant
Aug 03
Form 4
40.00K
Jan 19, 2006
40.00K
Grant
Jan 17
Form 4
40.00K
Jun 23, 2005
40.00K
Grant
Jun 21
Form 4
60.00K
Jan 25, 2005
60.00K
Grant
Jan 21
Form 4
150.00K
$1.84
$276.00K
May 12, 2004
150.00K
Grant
May 10
Form 3
May 12, 2004
Showing 34 results

NPS PHARMACEUTICALS INC

Investor
Updated Feb 24, 2015
Form 4
-100.00%
-93.89K
$46.00
-$1.12M
Feb 24, 2015
Disposition
Feb 21
Form 4
3.82K
Feb 20, 2015
3.82K
Grant
Feb 12
Form 4
18.80%
4.57K
Feb 14, 2014
28.89K
Options
Feb 12 - Feb 13
Form 4
15.19K
Feb 15, 2013
15.19K
Grant
Feb 13
Form 4
9.13K
$8.74
-$53.31K
Feb 11, 2013
9.13K
Acq/Dis
ScheduledFeb 07
Form 4
1.37%
403.00
May 23, 2012
29.76K
Grant
May 16
Form 4
15.22K
Feb 09, 2012
15.23K
Grant
Feb 07
Form 4
8.41%
2.28K
Jan 19, 2012
29.36K
Grant
Jan 17
Form 4
9.10%
2.26K
Oct 19, 2011
27.08K
Grant
Oct 17
Form 4
6.78%
1.58K
Jul 19, 2011
24.82K
Grant
Jul 15
Form 4
6.94%
1.51K
May 23, 2011
23.24K
Grant
May 19
Form 4
8.44%
1.69K
Apr 19, 2011
21.74K
Grant
Apr 15
Form 4
10.47%
1.90K
Jan 20, 2011
20.04K
Grant
Jan 18
Form 4
14.31%
2.27K
Oct 19, 2010
18.15K
Grant
Oct 15
Form 4
18.69%
2.50K
Jul 19, 2010
15.87K
Grant
Jul 15
Form 4
18.25%
2.06K
May 24, 2010
13.37K
Grant
May 20
Form 4
28.55%
2.51K
Apr 19, 2010
11.31K
Grant
Apr 15
Form 4
110.03%
4.61K
Jan 19, 2010
8.80K
Grant
Jan 15
Form 4
4.19K
Oct 16, 2009
4.19K
Grant
Oct 15
Form 4
36.00K
Jul 13, 2009
36.00K
Grant
Jul 09
Form 3
Jul 13, 2009
Showing 21 results